South Korea’s Largest IPO Since 2017 Starts Taking Orders
This article is for subscribers only.
SK Biopharmaceuticals Co. has started taking investor orders for what is set to be South Korea’s largest initial public offering in three years.
The company could raise as much as 959 billion won ($805 million) at the top of its price range. The sale comes as IPOs globally rebound, with last week being the biggest of the year for listings.